HUM Humana Inc. Common Stock

NYSE · Health Care · Wyświetl na SEC EDGAR ↗
$382,25
Cena · Sie 19, 2026
Dane fundamentalne na dzień Lip 29, 2026

O Humana Inc. Common Stock Przegląd firmy z Wikipedii

Humana Inc. is an American for-profit health insurance company based in Louisville, Kentucky. In 2024, the company ranked 92 on the Fortune 500 list, which made it the highest ranked company based in Kentucky. It is the fourth largest health insurance provider in the U.S.

Czytaj więcej

Humana Inc. is an American for-profit health insurance company based in Louisville, Kentucky. In 2024, the company ranked 92 on the Fortune 500 list, which made it the highest ranked (by revenues) company based in Kentucky. It is the fourth largest health insurance provider in the U.S.

History

1961–1983: Nursing homes and hospitals

Lawyers David A. Jones Sr. and Wendell Cherry founded a nursing home company in 1961. The company, known in 1968 as Extendicare Inc., became the largest nursing home company in the United States. In 1972, Jones and Cherry sold the nursing home chain to purchase hospitals. Humana became one of the first two for-profit hospital ventures in the U.S. along with Hospital Corporation of America (HCA).

In 1974, the partners changed the corporate name to Humana Inc. The name was meant to change public perception from 'warehousing' or indifferently treating people to providing a higher level of human care and, by extension, more humane care. It grew in the following years, both by business and in 1978 through the takeover of American Medicorp Inc., which doubled the company's size, and grew into the world's largest hospital company in the 1980s. During this period, Humana developed the double corridor model for hospital construction. This design minimized the distance between patients and nurses by placing nursing support services in the interior of the building with patient rooms surrounding the perimeter.

1984–present

As the American health care system changed in the 1980s, "one of its hospitals in Arizona lost a contract with the largest health-maintenance organization in the area [and] Humana created its own health insurance plan."

In 1993, Humana had become the largest hospital operator in the country, owning 77 hospitals. Humana executives spun off hospital operations from health insurance operations to create Galen Health Care. The following year they sold the 73 hospitals of Galen Health Care Inc. to Nashville-based Columbia Hospital Corporation of America for $3.4 billion.

In 1998, one year after Jones had stepped aside as CEO, UnitedHealthcare made an unsuccessful attempt to acquire Humana. Humana pulled out of the acquisition after United stock dropped $2.9 billion in value. In 2001, Humana was a cofounder of Availity.

In 2005, Humana entered into a business partnership with Virgin Group, offering financial incentives to members for healthy behavior, such as regular exercise.

On November 16, 2006, the Centers for Disease Control and Prevention (CDC) and Humana Inc. partnered to expand on traditional private-sector approaches to population health management.

In 2010, Humana bought Texas-based Concentra Inc., which owns urgent-care and physical therapy centers, for $790 million, effectively returning to healthcare services. In May 2011, Humana announced it would be using mobileStorm to transmit protected health information to patients.

In March 2015, Humana announced the sale of Concentra to private equity firm Welsh, Carson, Anderson & Stowe and Select Medical Holdings Corporation for about $1 billion, with proceeds to fund a "$2 billion share buyback program and other corporate spending."

In July 2015, Aetna announced that it would acquire Humana for $37 billion in cash and stock (approximately $230 a share at that time). Aetna and Humana shareholders would own 74% and 26% of the new combined company. However, the U.S. Department of Justice's Antitrust Division alleged the acquisition would be anticompetitive and sued to block the transaction. Following a trial, U.S. district judge John D. Bates of the United States District Court for the District of Columbia agreed and issued an injunction blocking the acquisition. In February 2017, Aetna Inc. and Humana Inc. quashed a $34 billion merger agreement after judges ruled against the merger for a second time.

In July 2018, Humana joined two private equity firms in the acquisition of Kindred Healthcare. The deal provided Humana with a 40% stake in the company's home health, hospice and community care businesses, called "Kindred at Home," for approximately $800 million. In August 2018, Humana announced the creation of a digital health and analytics division called Humana Studio H.

In December 2019, the company announced it would acquire Enclara Healthcare from Consonance Capital Partners and Enclara management.

In 2021, Susan Diamond, formerly occupying an interim position, was announced to be the new permanent CFO. Her appointment to the position comes with the company's focus being turned towards the home healthcare business, acquiring in April of the same year a 60% stake in Kindred at Home, an in-home care and hospice business.

In April 2022, it was announced Humana would sell a 60% interest of its Kindred at Home division to the private investment company, Clayton, Dubilier & Rice, for US$2.8 billion.

In February 2023, Humana announced they were exiting the employer-based commercial group insurance market.

Corporate affairs

Sponsorship

Humana is the presenting sponsor of the Grand Ole Opry and the National Senior Games.

Since 1979, Humana has been a principal sponsor of the annual Humana Festival of New American Plays in Louisville, Kentucky.

Humana was a tour partner of the PGA Tour beginning from 2005 to 2015.

The Humana Distaff Handicap is a Grade 1 race for thoroughbred fillies and mares, four-years-old and up. The race is run each spring on Kentucky Derby day at Churchill Downs and set at a distance of 7 furlongs for a purse of $250,000.

Humana Military Healthcare Services

In 1993, Humana founded Humana Military Healthcare Services (HMHS) as a wholly owned subsidiary. They were awarded their first TRICARE contract in 1995, and began serving military beneficiaries in 1996.

From 2004 to 2009, HMHS was the managed care contractor for the Department of Defense Military Health System TRICARE South Region.

In 2009, HMHS' Managed Care Support Contract was awarded to United Military and Veterans Services, a subsidiary of UnitedHealth Group. HMHS protested that decision and the Government Accountability Office upheld the protest in late 2009.

In 2011, HMHS regained the five-year contract to administer medical benefits to military members and families in the South region, a contract worth $23.5 billion. In 2018, this was moved to the new TRICARE East region during the TRICARE regional realignment.

On December 22, 2022, the Department of Defense announced the award of the managed care support contract for the TRICARE East Region to Humana Military.

Legal campaign against drug price fixing

Humana filed a lawsuit in August 2019, alleging that 37 defendants engaged in a “far-reaching conspiracy” to “blatantly fix the price” of generic drugs. This follows a similar smaller lawsuit from October 2018.

Controversy

In 1987, Humana sued NBC over a story line in the television medical drama St. Elsewhere in which the hospital was to be sold to a for-profit medical corporation and renamed "Ecumena", with subsequent changes to the hospital, both positive and negative, emanating from that change. The company claimed that the program infringed on the Humana trademark. Humana failed to block the airing of the show, but was successful at forcing NBC into showing a disclaimer at the beginning of the September 30 episode saying that the drama had no connection whatsoever with Humana.

On May 30, 1996, Linda Peeno, a physician who was contracted to work for Humana for nine months, testified before Congress as to the downside of managed care. Peeno said she was effectively rewarded by her employer for causing the death of a patient, because it saved the company a half-million dollars. Peeno stated that she felt the "managed care" model was inherently unethical.

In 1999, season one of Michael Moore's TV series The Awful Truth reported on Humana refusing to pay for a diabetic patient with pancreatic failure needing a transplant. The man's policy stated it covered all of his diabetes-related expenses, but another section of the policy stated that it did not cover organ transplants. Moore conducted a fake funeral on the front steps of the Humana building, and three days later Humana changed its policy and authorized the man's treatment.

Michael Moore's 2007 documentary Sicko used the video of Linda Peeno's testimony. On June 28, 2007, Humana declared that Peeno was never a Humana "associate" (permanent, full-time employee), but rather a "part-time contractor." Humana disputed portions of her Congressional testimony by saying that because the patient's healthcare plan did not cover heart transplants, denial of coverage was valid.

On September 21, 2009, the U.S. Dept. of Health and Human Services opened an investigation into Humana for sending flyers to Medicare recipients that the AARP characterized as deceptive. The mail was made to appear to contain official information about Medicare Advantage and prescription drug benefit information, but instead alleged that core Medicare benefits could be cut by the Obama administration's healthcare reform, a claim refuted by John Rother, AARP's executive vice president. Douglas Elmendorf, the head of the Congressional Budget Office (CBO), supported the claim that Medicare benefits could be cut, but his comments were in reference to just one of several congressional bills. CBO estimates of another healthcare reform bill found that changes to premiums would vary. The Centers for Medicare and Medicaid Services instructed Humana to cease all such mailings to Medicare plan members pending an investigation. HHS Secretary Kathleen Sebelius, in a letter to the insurance industry, threatened that bad actors may be excluded from new health insurance markets that were to open in 2014. Senate Republicans pointed out in a letter to Sebelius that a 1997 directive from the Centers for Medicare and Medicaid Services explicitly allowed HMOs to tell members about legislation and urge them to express opinions.

Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗

Wikidata ↗

HUM Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy

Cena
$382.25
Kapitalizacja Rynkowa
$75.96B
P/E (TTM)
38.8
EPS (TTM)
$9.84
Przychody (TTM)
$129.66B
Stopa dywidendy
0.56%
ROE
7.0%
D/E Dług/Kapitał
0.7
Zakres 52 tyg.
$163 – $429

HUM Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok

Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS

Przychody i Zysk Netto $129.66B
10-point trend, +138.4%
2016-12-31 2025-12-31
EPS $9.84
10-point trend, +141.8%
2016-12-31 2025-12-31
Wolny przepływ pieniężny $375M
10-point trend, -73.4%
2016-12-31 2025-12-31
Marże 0.92%

Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?

Wskaźnik
Trend 5-letni
HUM
Mediana porównawcza
P/E (TTM)
5-point trend, +27.2%
38.8
36.8
P/S (TTM)
4-point trend, -64.2%
0.6
0.8
P/B
4-point trend, -56.6%
4.3
3.4
EV / EBITDA
4-point trend, -33.7%
25.3
Price / FCF (Cena / FCF)
4-point trend, +362.5%
202.6

Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC

Wskaźnik
Trend 5-letni
HUM
Mediana porównawcza
Operating Margin (Marża Operacyjna)
5-point trend, -44.9%
2.1%
Net Profit Margin (Marża Zysku Netto)
5-point trend, -73.9%
0.92%
0.85%
ROA
5-point trend, -66.3%
2.5%
2.8%
ROE
5-point trend, -61.5%
7.0%
8.2%
ROIC
5-point trend, -26.6%
7.4%

Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu

Wskaźnik
Trend 5-letni
HUM
Mediana porównawcza
Debt / Equity (Dług / Kapitał Własny)
5-point trend, +7.0%
0.7
Current Ratio (Wskaźnik bieżący)
5-point trend, +23.3%
2.0
1.5
Quick Ratio (Wskaźnik Szybkości)
5-point trend, +18.1%
1.4

Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni

Wskaźnik
Trend 5-letni
HUM
Mediana porównawcza
Revenue YoY (Przychody R/R)
5-point trend, +56.1%
10.1%
Revenue CAGR 3Y (Przychody CAGR 3L)
5-point trend, +56.1%
11.8%
Revenue CAGR 5Y (Przychody CAGR 5L)
5-point trend, +56.1%
10.9%
EPS YoY
5-point trend, -56.6%
-1.4%
Net Income YoY (Zysk Netto R/R)
5-point trend, -59.5%
-1.6%

Wskaźniki na akcję EPS, wartość księgowa na akcję, przepływy pieniężne na akcję, dywidenda na akcję

Wskaźnik
Trend 5-letni
HUM
Mediana porównawcza
EPS (Diluted) (EPS (Rozwodniony))
5-point trend, -56.6%
$9.84

Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności

Wskaźnik
Trend 5-letni
HUM
Mediana porównawcza
Payout Ratio (Wskaźnik Wypłaty Dywidendy)
5-point trend, +199.9%
36.2%

Dywidendy Stopa dywidendy, wskaźnik wypłaty, historia dywidend, 5-letni CAGR

Stopa Dywidendy
0.56%
Wskaźnik Wypłaty Dywidendy
36.2%
CAGR dywidendy 5-letni
Data ex-dywidendyKwota
26 czerwca 2026$0,8850
27 marca 2026$0,8850
26 grudnia 2025$0,8850
26 września 2025$0,8850
27 czerwca 2025$0,8850
28 marca 2025$0,8850
31 grudnia 2024$0,8850
30 września 2024$0,8850
28 czerwca 2024$0,8850
27 marca 2024$0,8850
28 grudnia 2023$0,8850
28 września 2023$0,8850
29 czerwca 2023$0,8850
30 marca 2023$0,8850
29 grudnia 2022$0,7880
29 września 2022$0,7880
29 czerwca 2022$0,7880
30 marca 2022$0,7880
30 grudnia 2021$0,7000
29 września 2021$0,7000

HUM Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu

KUP 33 analityków
  • Mocne kupno 8 24,2%
  • Kup 8 24,2%
  • Trzymaj 15 45,5%
  • Sprzedaj 2 6,1%
  • Mocna sprzedaż 0 0,0%

12-miesięczny cel cenowy

23 analityków · 2026-08-19
Średni cel $415.00 +8,6%
Średnia cel $416.43 +8,9%

Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników

Średnie zaskoczenie
0.42%
Okres EPS Actual EPS Szacowany Niespodzianka
30 czerwca 2026 $7.61 $7.29 0.32%
31 marca 2026 $10.31 $10.29 0.02%
31 grudnia 2025 $-3.96 $-4.05 0.09%
30 września 2025 $3.24 $2.85 0.39%
30 czerwca 2025 $6.27 $5.98 0.29%
31 marca 2025 $11.58 $10.17 1.4%

Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora

Ticker Kapitalizacja Rynkowa P/E Przychody r/r Marża Netto ROE Marża brutto
HUM $50.90B 26.0 10.1% 0.92% 7.0%
UNH $299.08B 25.0 11.8% 2.7% 12.0%
ELV $77.37B 13.9 12.5% 2.8% 13.3%
CNC $20.24B -3.0 19.4% -3.4% -28.8% 7.3%
MOH $8.85B 19.5 11.8% 1.0% 10.9%
HQY $7.12B 34.0 9.5% 16.4% 10.1% 69.5%
ALHC $4.03B 46.1% -0.02% -0.52%
CLOV -5.1 40.3% -4.5% -26.2%
PGNY $2.14B 39.5 10.4% 4.5% 11.3% 23.6%

Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne

Rachunek zysków i strat 13
Dane roczne Rachunek zysków i strat dla HUM
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Revenue 12-point trend, +167.3% $129.66B $117.76B $106.37B $92.87B $83.06B $77.16B $64.89B $56.91B $53.77B $54.38B $54.29B $48.50B
SG&A Expense 12-point trend, +102.3% $15.45B $13.70B $13.19B $12.67B $10.12B $10.05B $7.38B $7.53B $6.57B $7.17B $7.29B $7.64B
Operating Income 12-point trend, +14.5% $2.70B $2.56B $4.01B $3.80B $3.15B $4.99B $3.19B $3.10B $4.26B $1.74B $2.35B $2.36B
Interest Expense 10-point trend, +156.8% · · $493M $401M $326M $283M $242M $218M $242M $189M $186M $192M
Other Non-op 10-point trend, -451000000.00 $-451M $-181M $-137M $-68M $532M $-103M $506M $-33M $0 $0 · ·
Pretax Income 12-point trend, -33.7% $1.44B $1.62B $3.33B $3.57B $3.42B $4.67B $3.47B $2.07B $4.02B $1.55B $2.43B $2.17B
Income Tax 12-point trend, -75.6% $250M $413M $836M $762M $485M $1.31B $763M $391M $1.57B $938M $1.16B $1.02B
Net Income 12-point trend, +3.6% $1.19B $1.21B $2.49B $2.81B $2.93B $3.37B $2.71B $1.68B $2.45B $614M $1.28B $1.15B
EPS (Basic) 12-point trend, +32.7% $9.87 $10.01 $20.09 $22.20 $22.79 $25.47 $20.20 $12.24 $16.94 $4.11 $8.54 $7.44
EPS (Diluted) 12-point trend, +33.7% $9.84 $9.98 $20.00 $22.08 $22.67 $25.31 $20.10 $12.16 $16.81 $4.07 $8.44 $7.36
Shares (Basic) 12-point trend, -21.9% 120,454,000 120,571,000 123,866,000 126,419,000 128,688,000 132,199,000 134,055,000 137,486,000 144,493,000 149,375,000 149,455,000 154,187,000
Shares (Diluted) 12-point trend, -22.5% 120,826,000 120,869,000 124,441,000 127,094,000 129,396,000 133,012,000 134,727,000 138,403,000 145,585,000 150,917,000 151,142,000 155,874,000
EBITDA 12-point trend, +14.5% $2.70B $2.56B $4.01B $3.80B $3.15B $4.99B $3.19B $3.10B $4.26B $1.74B $2.35B $2.36B
Bilans 26
Dane roczne Bilans dla HUM
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Cash & Equivalents 12-point trend, +117.1% $4.20B $2.22B $4.69B $5.06B $3.39B $4.67B $4.05B $2.34B $4.04B $3.88B $2.57B $1.94B
Short-term Investments 7-point trend, +43.1% $15.70B $18.21B $16.63B $13.88B $13.19B $12.55B $10.97B · · · · ·
Receivables 12-point trend, +210.5% $3.27B $2.70B $2.04B $1.67B $1.81B $1.14B $1.06B $1.01B $854M $1.28B $1.16B $1.05B
Other Current Assets 12-point trend, +138.6% $9.56B $6.68B $6.63B $5.57B $6.49B $5.28B $3.81B $3.56B $2.95B $3.44B $4.71B $4.01B
Current Assets 12-point trend, +110.7% $32.73B $29.82B $29.99B $26.18B $24.89B $23.64B $19.89B $16.95B $17.40B $16.19B $15.71B $15.54B
PP&E (Net) 12-point trend, +81.7% $2.23B $2.53B $3.03B $3.22B $3.07B $2.37B $1.96B $1.74B $1.58B $1.50B $1.38B $1.23B
PP&E (Gross) 12-point trend, +89.9% $5.52B $5.67B $5.88B $6.36B $5.95B $5.49B $4.62B $4.05B $3.56B $3.19B $2.72B $2.91B
Accum. Depreciation 12-point trend, +95.8% $3.29B $3.14B $2.85B $3.14B $2.87B $3.12B $2.66B $2.31B $1.98B $1.69B $1.34B $1.68B
Goodwill 12-point trend, +199.8% $9.69B $9.63B $9.55B $9.14B $11.09B $4.45B $3.93B $3.90B $3.28B $3.27B $3.27B $3.23B
Intangibles 12-point trend, +156.4% $1.13B $1.44B $1.69B $1.76B $2.64B $329M $177M $245M $226M $280M $357M $440M
Other Non-current Assets 12-point trend, +97.6% $3.13B $3.38B $3.38B $3.38B $4.38B $2.13B $1.83B $1.38B $2.17B $2.23B $2.48B $1.58B
Total Assets 12-point trend, +107.9% $48.91B $46.48B $47.06B $43.05B $44.36B $34.97B $29.07B $25.41B $27.18B $25.40B $24.68B $23.53B
Accounts Payable 12-point trend, +172.9% $5.72B $5.26B $6.57B $5.24B $4.51B $4.01B $3.75B $3.07B $4.07B $2.47B $2.21B $2.10B
Short-term Debt 5-point trend, +1694000000.00 · · · · · · · $1.69B $150M $300M $299M $0
Current Liabilities 12-point trend, +118.8% $16.35B $16.94B $18.87B $17.18B $15.33B $13.39B $10.93B $10.08B $9.41B $7.82B $8.15B $7.47B
Capital Leases 7-point trend, +25.9% $418M $392M $444M $456M $546M $355M $332M · · · · ·
Other Non-current Liabilities 12-point trend, +941.1% $2.46B $1.95B $1.66B $1.47B $2.38B $1.79B $1.14B $581M $237M $263M $235M $236M
Total Liabilities 12-point trend, +124.6% $31.17B $30.03B $30.75B $27.68B $28.25B $21.24B $17.04B $15.25B $17.34B $14.71B $14.33B $13.88B
Total Debt 12-point trend, +223.4% $12.37B $11.14B $10.21B $9.03B $10.54B $6.06B $4.97B $6.07B $4.92B $4.09B $4.12B $3.83B
Common Stock Flat — no change across 12 periods $33M $33M $33M $33M $33M $33M $33M $33M $33M $33M $33M $33M
Retained Earnings 12-point trend, +193.2% $29.07B $28.32B $27.54B $25.49B $23.09B $20.52B $17.48B $15.07B $13.67B $11.45B $11.02B $9.92B
Treasury Stock 12-point trend, +404.8% $14.42B $14.37B $13.66B $12.16B $10.16B $9.92B $8.46B $7.32B $6.33B $3.30B $3.29B $2.86B
AOCI 12-point trend, -383.9% $-633M $-1.07B $-999M $-1.30B $42M $391M $156M $-159M $19M $-66M $58M $223M
Stockholders' Equity 12-point trend, +83.0% $17.66B $16.38B $16.26B $15.31B $16.08B $13.73B $12.04B $10.16B $9.84B $10.69B $10.35B $9.65B
Liabilities + Equity 12-point trend, +107.9% $48.91B $46.48B $47.06B $43.05B $44.36B $34.97B $29.07B $25.41B $27.18B $25.40B $24.68B $23.53B
Shares Outstanding 7-point trend, +0.0% 198,719,000 198,719,000 198,690,000 198,667,000 198,649,000 198,649,000 198,630,000 · · · · ·
Przepływy pieniężne 17
Dane roczne Przepływy pieniężne dla HUM
Wskaźnik Trend 202520242023202220212020201920182017201620152014
D&A 10-point trend, +112.8% $698M $839M $779M $709M $596M · · $444M $410M $388M $354M $328M
Stock-based Comp 12-point trend, +145.9% $241M $207M $175M $216M $180M $181M $163M $137M $157M $115M $109M $98M
Deferred Tax 12-point trend, +217.2% $75M $-192M $-164M $-100M $15M $195M $162M $194M $132M $-71M $-2M $-64M
Amort. of Intangibles 12-point trend, -57.9% $51M $60M $67M $81M $65M $88M $70M $90M $75M $77M $93M $121M
Restructuring 2-point trend, -68.2% · · · · · · $47M · $148M · · ·
Operating Cash Flow 12-point trend, -43.1% $921M $2.97B $3.98B $4.59B $2.26B $5.64B $5.28B $2.17B $4.05B $1.94B $868M $1.62B
CapEx 12-point trend, +3.4% $546M $575M $1.00B $1.14B $1.34B $964M $736M $612M $524M $527M $523M $528M
Investing Cash Flow 12-point trend, +3707.9% $2.27B $-2.95B $-3.49B $-1.01B $-6.56B $-3.06B $-1.28B $-3.09B $-2.94B $-1.36B $320M $-63M
Net Debt Issued 6-point trend, +20.0% · · · · · · $-400M $0 $-800M $0 $0 $-500M
Stock Repurchased 12-point trend, -82.7% $151M $817M $1.57B $2.10B $79M $1.82B $1.07B $1.09B $3.37B $104M $385M $872M
Net Stock Activity 12-point trend, +82.7% $-151M $-817M $-1.57B $-2.10B $-79M $-1.82B $-1.07B $-1.09B $-3.37B $-104M $-385M $-872M
Dividends Paid 12-point trend, +150.0% $430M $431M $431M $392M $354M $323M $291M $265M $220M $177M $172M $172M
Financing Cash Flow 12-point trend, -60.3% $-1.22B $-2.49B $-856M $-1.91B $3.02B $-1.96B $-2.29B $-785M $-945M $732M $-552M $-758M
Net Change in Cash 12-point trend, +148.3% $1.98B $-2.47B $-367M $1.67B $-1.28B $619M $1.71B $-1.70B $165M $1.31B $636M $797M
Taxes Paid 11-point trend, -44.7% · $570M $997M $758M $227M $1.13B $518M $631M $1.50B $916M $1.18B $1.03B
Free Cash Flow 12-point trend, -65.6% $375M $2.39B $2.98B $3.47B $946M $4.67B $4.55B $1.56B $3.52B $1.41B $345M $1.09B
Levered FCF 10-point trend, +163.8% · · $2.61B $3.15B $666M $4.47B $4.36B $1.38B $3.38B $1.33B $247M $989M
Rentowność 7
Dane roczne Rentowność dla HUM
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Operating Margin 12-point trend, -57.1% 2.1% 2.2% 3.8% 4.1% 3.8% 6.5% 4.9% 5.5% 7.9% 3.2% 4.3% 4.9%
Net Margin 12-point trend, -61.0% 0.92% 1.0% 2.3% 3.0% 3.5% 4.4% 4.2% 3.0% 4.5% 1.1% 2.4% 2.4%
Pretax Margin 12-point trend, -75.2% 1.1% 1.5% 3.1% 3.8% 4.1% 6.1% 5.3% 3.6% 7.5% 2.9% 4.5% 4.5%
EBITDA Margin 12-point trend, -57.1% 2.1% 2.2% 3.8% 4.1% 3.8% 6.5% 4.9% 5.5% 7.9% 3.2% 4.3% 4.9%
ROA 12-point trend, -52.0% 2.5% 2.6% 5.5% 6.4% 7.4% 10.5% 9.9% 6.4% 9.3% 2.5% 5.3% 5.2%
ROE 12-point trend, -42.3% 7.0% 7.4% 15.8% 18.2% 18.1% 22.8% 22.9% 16.2% 23.3% 5.8% 12.8% 12.1%
ROIC 12-point trend, -19.7% 7.4% 7.1% 11.3% 12.3% 10.1% 18.1% 14.6% 15.5% 17.6% 4.7% 8.5% 9.3%
Płynność i wypłacalność 5
Dane roczne Płynność i wypłacalność dla HUM
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Current Ratio 12-point trend, +0.1% 2.0 1.8 1.6 1.5 1.6 1.8 1.8 1.7 1.9 2.1 1.9 2.0
Quick Ratio 12-point trend, +236.0% 1.4 1.4 1.2 1.2 1.2 1.4 0.5 0.3 0.5 0.7 0.5 0.4
Debt / Equity 12-point trend, +76.7% 0.7 0.7 0.6 0.6 0.7 0.4 0.4 0.6 0.5 0.4 0.4 0.4
LT Debt / Equity 12-point trend, +76.7% 0.7 0.7 0.6 0.6 0.7 0.4 0.4 0.4 0.5 0.4 0.4 0.4
Interest Coverage 10-point trend, -33.8% · · 8.1 9.5 9.7 17.6 13.2 14.2 17.6 9.2 12.6 12.3
Efektywność 2
Dane roczne Efektywność dla HUM
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Asset Turnover 12-point trend, +23.9% 2.7 2.5 2.4 2.1 2.1 2.4 2.4 2.2 2.0 2.2 2.3 2.2
Receivables Turnover 12-point trend, -5.2% 43.4 49.7 57.4 53.3 56.3 70.3 62.7 60.9 50.4 44.6 49.0 45.8
Na akcję 7
Dane roczne Na akcję dla HUM
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Book Value / Share 4-point trend, +15.3% $88.85 $82.40 $81.85 $77.07 · · · · · · · ·
Revenue / Share 12-point trend, +244.9% $1073.15 $974.29 $854.81 $730.72 $641.94 $580.06 $481.63 $411.20 $369.32 $360.32 $359.19 $311.15
Cash Flow / Share 12-point trend, -26.6% $7.62 $24.54 $31.99 $36.09 $17.48 $42.39 $39.22 $15.70 $27.83 $12.83 $5.74 $10.38
Cash / Share 4-point trend, -17.0% $21.14 $11.18 $23.62 $25.47 · · · · · · · ·
Dividend / Share 3-point trend, +4.5% · · · · · · · · · $1 $1 $1
Dividend Paid / Share 12-point trend, +221.8% $4 $4 $3 $3 $3 $2 $2 $2 $1 $1 $1 $1
EPS (TTM) 12-point trend, +33.7% $9.84 $9.98 $20.00 $22.08 $22.67 $25.31 $20.10 $12.16 $16.81 $4.07 $8.44 $7.36
Stopy Wzrostu 10
Dane roczne Stopy Wzrostu dla HUM
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Revenue YoY 5-point trend, +32.0% 10.1% 10.7% 14.5% 11.8% 7.7% · · · · · · ·
Revenue CAGR 3Y 3-point trend, +4.2% 11.8% 12.3% 11.3% · · · · · · · · ·
Revenue CAGR 5Y 10.9% · · · · · · · · · · ·
EPS YoY 5-point trend, +86.6% -1.4% -50.1% -9.4% -2.6% -10.4% · · · · · · ·
EPS CAGR 3Y 3-point trend, -212.8% -23.6% -23.9% -7.5% · · · · · · · · ·
EPS CAGR 5Y -17.2% · · · · · · · · · · ·
Net Income YoY 5-point trend, +87.8% -1.6% -51.5% -11.3% -4.3% -12.9% · · · · · · ·
Net Income CAGR 3Y 3-point trend, -160.0% -24.9% -25.6% -9.6% · · · · · · · · ·
Net Income CAGR 5Y -18.8% · · · · · · · · · · ·
Dividend CAGR 5Y 5.9% · · · · · · · · · · ·
Wycena (TTM) 17
Dane roczne Wycena (TTM) dla HUM
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Revenue TTM 12-point trend, +167.3% $129.66B $117.76B $106.37B $92.87B $83.06B $77.16B $64.89B $56.91B $53.77B $54.38B $54.29B $48.50B
Net Income TTM 12-point trend, +3.6% $1.19B $1.21B $2.49B $2.81B $2.93B $3.37B $2.71B $1.68B $2.45B $614M $1.28B $1.15B
Market Cap 4-point trend, -50.0% $50.90B $50.42B $90.96B $101.76B · · · · · · · ·
Enterprise Value 4-point trend, -52.8% $43.36B $41.13B $79.86B $91.85B · · · · · · · ·
P/E 12-point trend, +33.4% 26.0 25.4 22.9 23.2 20.5 16.2 18.2 23.6 14.8 50.1 21.2 19.5
P/S 4-point trend, -64.2% 0.4 0.4 0.9 1.1 · · · · · · · ·
P/B 4-point trend, -56.6% 2.9 3.1 5.6 6.6 · · · · · · · ·
P / Tangible Book 4-point trend, -67.8% 7.4 9.5 18.1 23.1 · · · · · · · ·
P / Cash Flow 4-point trend, +149.1% 55.3 17.0 22.8 22.2 · · · · · · · ·
P / FCF 4-point trend, +362.5% 135.7 21.1 30.6 29.3 · · · · · · · ·
EV / EBITDA 4-point trend, -33.7% 16.0 16.1 19.9 24.2 · · · · · · · ·
EV / FCF 4-point trend, +336.5% 115.6 17.2 26.8 26.5 · · · · · · · ·
EV / Revenue 4-point trend, -66.2% 0.3 0.3 0.8 1.0 · · · · · · · ·
Dividend Yield 4-point trend, +115.4% 0.84% 0.85% 0.47% 0.39% · · · · · · · ·
Earnings Yield 12-point trend, -25.0% 3.8% 3.9% 4.4% 4.3% 4.9% 6.2% 5.5% 4.2% 6.8% 2.0% 4.7% 5.1%
Payout Ratio 12-point trend, +141.3% 36.2% 35.7% 17.3% 14.0% 12.1% 9.6% 10.8% 15.8% 9.0% 28.8% 13.5% 15.0%
Annual Payout 12-point trend, +150.0% $430M $431M $431M $392M $354M $323M $291M $265M $220M $177M $172M $172M

Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat

Rachunek zysków i strat
2025-12-312024-12-312023-12-312022-12-312021-12-31
Przychody $129.66B$117.76B$106.37B$92.87B$83.06B
Marża Operacyjna % 2.1%2.2%3.8%4.1%3.8%
Zysk netto $1.19B$1.21B$2.49B$2.81B$2.93B
Rozwodniony EPS $9.84$9.98$20.00$22.08$22.67
Bilans
2025-12-312024-12-312023-12-312022-12-312021-12-31
Dług / Kapitał Własny 0.70.70.60.60.7
Wskaźnik bieżący 2.01.81.61.51.6
Wskaźnik Szybkości 1.41.41.21.21.2
Przepływy pieniężne
2025-12-312024-12-312023-12-312022-12-312021-12-31
Wolny przepływ pieniężny $375M$2.39B$2.98B$3.47B$946M

Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie

Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów

📊

Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.

Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.

Właściciele instytucjonalni (13F) 1 050 emitentów · $33.7B łącznie · Na dzień 30 czerwca 2026

Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.

Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
Nowe pozycje Zamknięte pozycje Zwiększone Zmniejszony Zmiana liczby akcji netto
255 (+143 vs poprzedni kw.) 81 (-80 vs poprzedni kw.) 313 (+42 vs poprzedni kw.) 273 (-45 vs poprzedni kw.) +23.7M

Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.

Instytucja Wartość Akcje % z śledzonych 13F Typ
Dodge & Cox $4 345 737 744 10 940 380 12,90% Akcje
VANGUARD CAPITAL MANAGEMENT LLC $3 115 642 737 7 843 620 9,25% Akcje
VANGUARD PORTFOLIO MANAGEMENT LLC $2 311 405 702 5 818 956 6,86% Akcje
STATE STREET CORP $2 172 441 313 5 457 072 6,45% Akcje
EAGLE CAPITAL MANAGEMENT LLC $1 528 010 749 3 846 762 4,54% Akcje
Sessa Capital IM, L.P. $1 480 732 883 3 727 740 4,40% Akcje
GEODE CAPITAL MANAGEMENT, LLC $1 181 074 714 2 976 242 3,51% Akcje
Capital International Investors $950 462 637 2 392 826 2,82% Akcje
NAYA CAPITAL MANAGEMENT UK LTD $728 407 339 1 833 763 2,16% Akcje
NORGES BANK $694 505 009 1 748 414 2,06% Akcje
GOLDMAN SACHS GROUP INC $659 096 868 1 659 274 1,96% Akcje
FMR LLC $615 633 048 1 549 854 1,83% Akcje
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $544 502 820 1 370 784 1,62% Akcje
Capital Research Global Investors $443 462 035 1 116 990 1,32% Akcje
Slate Path Capital LP $428 969 795 1 079 930 1,27% Akcje
Capital World Investors $406 119 738 1 022 425 1,21% Akcje
Newport Trust Company, LLC $384 768 345 968 653 1,14% Akcje
CITADEL ADVISORS LLC $363 376 856 914 800 1,08% Opcja kupna
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC $348 908 912 878 377 1,04% Akcje
DIMENSIONAL FUND ADVISORS LP $331 490 508 834 526 0,98% Akcje
BARROW HANLEY MEWHINNEY & STRAUSS LLC $314 921 577 792 814 0,93% Akcje
CITADEL ADVISORS LLC $310 904 094 782 700 0,92% Opcja sprzedaży
WELLINGTON MANAGEMENT GROUP LLP $282 117 958 710 231 0,84% Akcje
VANGUARD FIDUCIARY TRUST CO $267 791 027 674 163 0,79% Akcje
Maple Rock Capital Partners Inc. $249 553 862 628 251 0,74% Akcje
Diamond Hill Capital Management, LLC (Investment Advisor) $245 555 446 618 185 0,73% Akcje
GOLDMAN SACHS GROUP INC $232 333 978 584 900 0,69% Opcja kupna
MARSHALL WACE, LLP $216 873 381 545 978 0,64% Akcje
CITADEL ADVISORS LLC $178 080 082 448 316 0,53% Akcje
High Ground Investment Management LLP $177 941 848 447 968 0,53% Akcje
1832 Asset Management L.P. $176 401 430 444 090 0,52% Akcje
BCV Asset Management Inc. $173 695 656 445 719 0,52% Akcje
BANK OF AMERICA CORP /DE/ $172 703 708 434 781 0,51% Akcje
Holocene Advisors, LP $165 040 541 415 489 0,49% Akcje
BNP PARIBAS FINANCIAL MARKETS $147 490 964 371 308 0,44% Akcje
MILLENNIUM MANAGEMENT LLC $140 098 700 352 698 0,42% Akcje
JANE STREET GROUP, LLC $137 080 622 345 100 0,41% Opcja kupna
Swiss National Bank $134 522 525 338 660 0,40% Akcje
JANE STREET GROUP, LLC $122 542 370 308 500 0,36% Opcja sprzedaży
STEADFAST CAPITAL MANAGEMENT LP $122 423 204 308 200 0,36% Akcje
BlackRock, Inc. $120 890 332 304 341 0,36% Akcje
Mitsubishi UFJ Asset Management Co., Ltd. $115 565 201 290 935 0,34% Akcje
VANGUARD ASSET MANAGEMENT, Ltd $109 135 401 274 748 0,32% Akcje
AMERIPRISE FINANCIAL INC $108 302 217 272 614 0,32% Akcje
Legal & General Group Plc $103 424 967 260 372 0,31% Akcje
Vanguard Global Advisers, LLC $103 330 825 260 135 0,31% Akcje
GOLDMAN SACHS GROUP INC $103 078 590 259 500 0,31% Opcja sprzedaży
NEUBERGER BERMAN GROUP LLC $102 585 352 258 258 0,30% Akcje
BANK OF NOVA SCOTIA $102 313 941 257 575 0,30% Akcje
RHUMBLINE ADVISERS $102 294 748 257 527 0,30% Akcje
Sumitomo Mitsui Trust Group, Inc. $101 464 685 255 437 0,30% Akcje
GLENVIEW CAPITAL MANAGEMENT, LLC $100 979 680 254 216 0,30% Akcje
Gotham Asset Management, LLC $89 318 889 224 860 0,27% Akcje
Balyasny Asset Management L.P. $87 965 958 221 454 0,26% Akcje
FIRST TRUST ADVISORS LP $85 094 587 214 226 0,25% Akcje
Ensign Peak Advisors, Inc $83 532 585 210 293 0,25% Akcje
ADAGE CAPITAL PARTNERS GP, L.L.C. $83 463 866 210 120 0,25% Akcje
Brandywine Global Investment Management, LLC $80 388 706 313 859 0,24% Akcje
California Public Employees Retirement System $80 274 587 202 091 0,24% Akcje
WOLVERINE TRADING, LLC $76 135 109 298 300 0,23% Opcja kupna
Camber Capital Management LP $73 344 000 300 000 0,22% Akcje
National Pension Service $70 860 473 178 391 0,21% Akcje
BARCLAYS PLC $70 472 788 177 415 0,21% Akcje
Susquehanna Portfolio Strategies, LLC $69 949 250 176 097 0,21% Akcje
Walleye Trading LLC $69 473 778 174 900 0,21% Opcja kupna
CANADA PENSION PLAN INVESTMENT BOARD $68 018 761 171 237 0,20% Akcje
ARGA Investment Management, LP $66 165 730 166 572 0,20% Akcje
ORBIMED ADVISORS LLC $65 183 802 164 100 0,19% Akcje
Solel Partners LP $64 742 888 162 990 0,19% Akcje
AMF Tjanstepension AB $61 961 951 155 989 0,18% Akcje
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $60 794 124 153 049 0,18% Akcje
Perpetual Ltd $57 945 659 145 878 0,17% Akcje
CI INVESTMENTS INC. $57 302 560 144 259 0,17% Akcje
AMERICAN CENTURY COMPANIES INC $56 575 256 142 426 0,17% Akcje
Squarepoint Ops LLC $56 047 742 141 100 0,17% Opcja sprzedaży
Aberdeen Group plc $53 345 852 134 298 0,16% Akcje
WOLVERINE TRADING, LLC $52 653 949 206 300 0,16% Opcja sprzedaży
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. $52 178 000 131 358 0,15% Akcje
ING GROEP NV $51 583 784 129 862 0,15% Akcje
Squarepoint Ops LLC $50 685 272 127 600 0,15% Opcja kupna
Walleye Trading LLC $49 573 056 124 800 0,15% Opcja sprzedaży
D. E. Shaw & Co., Inc. $46 514 462 117 100 0,14% Opcja kupna
BRAIDWELL LP $45 481 690 114 500 0,14% Akcje
Jain Global LLC $43 694 200 110 000 0,13% Opcja sprzedaży
BANK OF MONTREAL /CAN/ $43 207 208 108 774 0,13% Akcje
Zurcher Kantonalbank (Zurich Cantonalbank) $42 190 325 106 214 0,13% Akcje
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM $42 127 167 106 055 0,13% Akcje
AVIVA PLC $41 509 093 104 499 0,12% Akcje
VIRGINIA RETIREMENT SYSTEMS ET Al $41 468 472 161 904 0,12% Akcje
ROYAL BANK OF CANADA $41 033 000 103 301 0,12% Akcje
Pentwater Capital Management LP $39 722 000 100 000 0,12% Opcja kupna
BNP PARIBAS ASSET MANAGEMENT Holding S.A. $39 284 661 98 899 0,12% Akcje
Point72 Asset Management, L.P. $39 122 595 98 491 0,12% Akcje
PFM Health Sciences, LP $37 487 638 94 375 0,11% Akcje
Summit Street Capital Management, LLC $36 325 372 91 449 0,11% Akcje
Columbus Hill Capital Management, L.P. $35 501 935 89 376 0,11% Akcje
Korea Investment CORP $34 579 193 87 053 0,10% Akcje
Quantinno Capital Management LP $32 817 091 82 616 0,10% Akcje
Fisher Funds Management LTD $32 811 563 82 603 0,10% Akcje
Swedbank AB $32 034 603 80 647 0,10% Akcje

Insiderzy spółki 76 insiderów · 46 dyrektorzy generalni · 27 dyrektorzy

Insider Rola Ostatnia aktywność Posiadane akcje Kupna 12m Sprzedaże 12m Netto 12m
James A. Rechtin President & CEO 14 maja 2025 P 30 474 0 0 $0
Bruce D Broussard Chief Executive Officer 21 lutego 2024 A 110 130 0 0 $0
Celeste Mellet Chief Financial Officer 24 lutego 2025 A 29 676 0 0 $0
Susan M Diamond Chief Financial Officer 31 grudnia 2024 J 20 165 0 0 $0
Brian A Kane Chief Financial Officer 22 lutego 2021 A 24 342 0 0 $0
Steven E Mcculley Interim CFO & Treasurer 9 maja 2014 G 14 916 0 0 $0
George Renaudin II President, Insurance 27 marca 2025 J 15 702 0 0 $0
David Dintenfass President, Enterprise Growth 24 lutego 2025 A 16 234 0 0 $0
Sanjay K Shetty President, CenterWell 24 lutego 2025 A 11 566 0 0 $0
M.D. Andrew C. Agwunobi, Seg. President, Home Solutions 24 lutego 2023 A 182 0 0 $0
Timothy Alan Wheatley Segment President, Retail 15 grudnia 2022 M 3 983 0 0 $0
Joseph William Jasser Seg. President, Care Delivery 15 grudnia 2017 M 222 0 0 $0
Thomas J Liston President - Retail Segment 18 lutego 2014 A 105 443 0 0 $0
James E Murray EVP & COO 31 marca 2017 J 34 668 0 0 $0
Japan Mehta Chief Information Officer 24 lutego 2025 A 8 628 0 0 $0
John-Paul W. Felter SVP, Chief Accting Off & Cont. 24 lutego 2025 A 1 767 0 0 $0
Michelle A. O'Hara Chief Human Resources Officer 24 lutego 2025 A 11 266 0 0 $0
Joseph C Ventura Chief Legal Officer 24 lutego 2025 A 17 267 0 0 $0
Vishal Agrawal Chief Strat & Corp Dev Officer 24 lutego 2025 A 16 717 0 0 $0
Timothy S. Huval Chief Administrative Officer 31 grudnia 2024 G 7 111 0 0 $0
Samir Deshpande Chief Information Officer 15 grudnia 2024 M 14 015 0 0 $0
William Kevin Fleming Chief Corporate Aff. Officer 21 lutego 2024 A 11 723 0 0 $0
Susan D. Schick Seg Pres. Grp. & Military Bus. 24 lutego 2023 F 3 687 0 0 $0
William H Shrank Chief Medical Officer 1 maja 2022 M 4 294 0 0 $0
Cynthia H Zipperle SVP, Chief Acct Officer & Cont 22 marca 2022 J 5 723 0 0 $0
Heather Cox Chief Dig Health & Analyt Off. 25 lutego 2022 F 6 014 0 0 $0
Christopher H. Hunter Seg Pres. Gr. & Military Bus. 16 marca 2021 G 8 168 0 0 $0
Elizabeth D Bierbower Strategic Advisor 18 grudnia 2019 M 18 092 0 0 $0
Brian P. Leclaire Strategic Advisor 15 grudnia 2019 M 6 339 0 0 $0
Jody L Bilney Chief Consumer Officer 25 lutego 2019 A 9 774 0 0 $0
Roy A Beveridge, Chief Medical Officer 19 lutego 2019 M 10 791 0 0 $0
Todoroff M Christopher Chief Legal Officer 15 grudnia 2018 M 11 136 0 0 $0
Heidi S Margulis Chief Corp. Affairs Officer 15 grudnia 2018 M 6 476 0 0 $0
Christopher E Kay SVP & Chief Innovation Officer 17 marca 2017 M 4 361 0 0 $0
Tim S Mcclain Group Pres, Govt & Other Busin 18 lutego 2014 A 1 101 0 0 $0
Bruce D Perkins Sgmt Pres, Healthcare Services 18 lutego 2014 A 15 946 0 0 $0
Paul B. K. Kusserow Sr VP & Ch Strat Dev Officer 24 czerwca 2013 M 19 347 0 0 $0
HATHCOCK BONNIE C Sr VP & Chief Human Res. Off 24 grudnia 2012 G 2 287 0 0 $0
Venkata R Madabhushi SVP & Chief Innov & Mrkting Of 28 kwietnia 2012 F 11 946 0 0 $0
GOODMAN BRUCE J Sr. VP 23 lutego 2012 A 23 280 0 0 $0
Jonathan T Lord MD Sr VP & Chief Innovation Off. 4 lutego 2009 I 0 0 0 $0
Arthur P Hipwell Senior Vice President 27 marca 2008 J 302 0 0 $0
Kathleen Pellegrino VP and Acting General Counsel 25 lutego 2008 F 13 836 0 0 $0
Steven O Moya Sr. VP-Chief Marketing Officer 31 grudnia 2007 I 0 0 0 $0
John M Bertko Vice President & Chief Actuary 23 lutego 2007 M 57 548 0 0 $0
Eugene R Shields Senior Vice President-Gov Prgm 6 stycznia 2005 M 0 0 0 $0
Kurt J Hilzinger Dyrektor 30 czerwca 2026 A 19 448 0 0 $0
Frank A Damelio Dyrektor 2 stycznia 2026 A 20 634 0 0 $0
Karen Katz Dyrektor 31 grudnia 2025 A 590 0 0 $0
David T Feinberg Dyrektor 30 czerwca 2025 A 441 0 0 $0

Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S

Aktywiści i właściciele 5%+ 1 akcja

Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.

Zgłaszający Złożono Udział Status Cel Zgłoszenie
David A. Jones ×2 zgłoszenia 12 listopada 2003 Pierwotne zgłoszenie SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Posiadanie ETF-ów Posiadane przez 200 funduszy ETF

Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.

Fundusz Waga Jednostki Na dzień Źródło
IHF · iShares Trust 4,29% 144 763 SH 8 sierpnia 2026 Dziennie
FXH · First Trust Exchange-Traded AlphaDE… 2,95% 109 132 NS 30 kwietnia 2026 N-PORT
SMRI · EA Series Trust 2,54% 58 016 NS 30 kwietnia 2026 N-PORT
RPV · Invesco Exchange-Traded Fund Trust 2,27% 100 446 SH 8 sierpnia 2026 Dziennie
TGLB · T. Rowe Price Exchange-Traded Funds… 2,26% 2 111 NS 30 kwietnia 2026 N-PORT
PTH · Invesco Exchange-Traded Fund Trust 1,80% 11 546 SH 8 sierpnia 2026 Dziennie
SRHQ · Elevation Series Trust 1,63% 13 322 NS 30 kwietnia 2026 N-PORT
RSPH · Invesco Exchange-Traded Fund Trust 1,60% 32 564 SH 8 sierpnia 2026 Dziennie
CVAR · ETF Opportunities Trust 1,51% 2 473 NS 30 kwietnia 2026 N-PORT
EPMV · Harbor ETF Trust 1,20% 225 NS 30 kwietnia 2026 N-PORT
ABCS · EA Series Trust 1,19% 441 NS 29 maja 2026 N-PORT
MFSV · MFS Active Exchange Traded Funds Tr… 1,14% 17 702 NS 31 maja 2026 N-PORT
NUMV · Nushares ETF Trust 0,96% 17 434 NS 30 kwietnia 2026 N-PORT
FTA · First Trust Exchange-Traded AlphaDE… 0,95% 52 223 NS 30 kwietnia 2026 N-PORT
VOE · VANGUARD INDEX FUNDS 0,82% 771 237 SH 8 sierpnia 2026 Dziennie
ITAN · EA Series Trust 0,77% 2 259 NS 29 maja 2026 N-PORT
CGMM · Capital Group Equity ETF Trust I 0,72% 65 925 NS 31 maja 2026 N-PORT
IYH · iShares Trust 0,72% 71 884 SH 8 sierpnia 2026 Dziennie
RWL · Invesco Exchange-Traded Fund Trust … 0,71% 183 164 SH 8 sierpnia 2026 Dziennie
VHT · VANGUARD WORLD FUND 0,70% 360 880 SH 8 sierpnia 2026 Dziennie
AUSF · Global X Funds 0,70% 19 401 NS 31 maja 2026 N-PORT
AVIE · AMERICAN CENTURY ETF TRUST 0,63% 211 NS 31 maja 2026 N-PORT
FVAL · FIDELITY COVINGTON TRUST 0,59% 30 459 NS 30 kwietnia 2026 N-PORT
IXJ · iShares Trust 0,56% 62 953 SH 8 sierpnia 2026 Dziennie
RXL · ProShares Trust 0,53% 1 258 NS 31 maja 2026 N-PORT
FAB · First Trust Exchange-Traded AlphaDE… 0,47% 2 755 NS 30 kwietnia 2026 N-PORT
VO · VANGUARD INDEX FUNDS 0,46% 2 601 869 SH 8 sierpnia 2026 Dziennie
FHLC · FIDELITY COVINGTON TRUST 0,46% 55 439 NS 30 kwietnia 2026 N-PORT
FEX · First Trust Exchange-Traded AlphaDE… 0,45% 28 340 NS 30 kwietnia 2026 N-PORT
DEUS · DBX ETF Trust 0,43% 3 849 NS 29 maja 2026 N-PORT
IWS · iShares Trust 0,42% 181 221 SH 8 sierpnia 2026 Dziennie
CURE · Direxion Shares ETF Trust 0,41% 2 404 NS 30 kwietnia 2026 N-PORT
SPXD · DBX ETF Trust 0,37% 81 NS 31 maja 2026 N-PORT
IMCV · iShares Trust 0,36% 11 394 SH 8 sierpnia 2026 Dziennie
QARP · DBX ETF Trust 0,36% 887 NS 29 maja 2026 N-PORT
VRP · Invesco Exchange-Traded Fund Trust … 0,35% 10 520 000 8 sierpnia 2026 Dziennie
PRF · Invesco Exchange-Traded Fund Trust 0,35% 90 057 SH 8 sierpnia 2026 Dziennie
AVMC · AMERICAN CENTURY ETF TRUST 0,34% 4 484 NS 31 maja 2026 N-PORT
GMOV · GMO ETF Trust 0,34% 1 004 NS 31 maja 2026 N-PORT
FNDX · SCHWAB STRATEGIC TRUST 0,32% 265 500 NS 31 maja 2026 N-PORT
IUS · Invesco Exchange-Traded Self-Indexe… 0,32% 7 839 SH 8 sierpnia 2026 Dziennie
IWR · iShares Trust 0,32% 489 015 SH 8 sierpnia 2026 Dziennie
IMCB · iShares Trust 0,30% 13 840 SH 8 sierpnia 2026 Dziennie
FNDB · SCHWAB STRATEGIC TRUST 0,29% 12 439 NS 31 maja 2026 N-PORT
PALC · Pacer Funds Trust 0,29% 2 779 NS 30 kwietnia 2026 N-PORT
SPVU · Invesco Exchange-Traded Fund Trust … 0,28% 1 250 NS 31 maja 2026 N-PORT
PFIG · Invesco Exchange-Traded Fund Trust … 0,28% 320 000 8 sierpnia 2026 Dziennie
BRCE · MFS Active Exchange Traded Funds Tr… 0,27% 299 NS 31 maja 2026 N-PORT
FFLC · FIDELITY COVINGTON TRUST 0,26% 12 272 NS 30 kwietnia 2026 N-PORT
VLUE · iShares Trust 0,24% 62 558 SH 8 sierpnia 2026 Dziennie